Saint Cergues, France

Walter Ferlin

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Walter Ferlin: Innovator in Monoclonal Antibodies

Introduction

Walter Ferlin is a prominent inventor based in Saint Cergues, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of nine patents to his name, Ferlin's work has had a substantial impact on therapeutic and diagnostic methods.

Latest Patents

One of Ferlin's latest patents is focused on Anti-IL-6/IL-6R antibodies and methods of use thereof. This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further outlines methods for using these monoclonal antibodies as therapeutic, diagnostic, and prophylactic agents. This innovative approach has the potential to revolutionize treatment options for various diseases.

Career Highlights

Walter Ferlin is currently associated with Novimmune SA, a company known for its cutting-edge research in immunology. His work at Novimmune has allowed him to explore and develop novel therapeutic solutions that address critical health challenges. His dedication to advancing medical science is evident in his extensive patent portfolio.

Collaborations

Ferlin has collaborated with notable colleagues, including Greg Elson and Olivier Leger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Walter Ferlin's contributions to the field of monoclonal antibodies exemplify the spirit of innovation in biotechnology. His work continues to pave the way for new therapeutic solutions that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…